Abstract |
The pathophysiology of ineffective erythropoiesis in β- thalassemia is poorly understood. We report that RAP-011, an activin receptor IIA (ActRIIA) ligand trap, improved ineffective erythropoiesis, corrected anemia and limited iron overload in a mouse model of β- thalassemia intermedia. Expression of growth differentiation factor 11 (GDF11), an ActRIIA ligand, was increased in splenic erythroblasts from thalassemic mice and in erythroblasts and sera from subjects with β- thalassemia. Inactivation of GDF11 decreased oxidative stress and the amount of α- globin membrane precipitates, resulting in increased terminal erythroid differentiation. Abnormal GDF11 expression was dependent on reactive oxygen species, suggesting the existence of an autocrine amplification loop in β- thalassemia. GDF11 inactivation also corrected the abnormal ratio of immature/mature erythroblasts by inducing apoptosis of immature erythroblasts through the Fas- Fas ligand pathway. Taken together, these observations suggest that ActRIIA ligand traps may have therapeutic relevance in β- thalassemia by suppressing the deleterious effects of GDF11, a cytokine which blocks terminal erythroid maturation through an autocrine amplification loop involving oxidative stress and α- globin precipitation.
|
Authors | Michael Dussiot, Thiago T Maciel, Aurélie Fricot, Céline Chartier, Olivier Negre, Joel Veiga, Damien Grapton, Etienne Paubelle, Emmanuel Payen, Yves Beuzard, Philippe Leboulch, Jean-Antoine Ribeil, Jean-Benoit Arlet, Francine Coté, Geneviève Courtois, Yelena Z Ginzburg, Thomas O Daniel, Rajesh Chopra, Victoria Sung, Olivier Hermine, Ivan C Moura |
Journal | Nature medicine
(Nat Med)
Vol. 20
Issue 4
Pg. 398-407
(Apr 2014)
ISSN: 1546-170X [Electronic] United States |
PMID | 24658077
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ACE-011
- Bone Morphogenetic Proteins
- Fas Ligand Protein
- GDF11 protein, human
- Gdf11 protein, mouse
- Growth Differentiation Factors
- Hematinics
- Ligands
- Reactive Oxygen Species
- Recombinant Fusion Proteins
- fas Receptor
- Activin Receptors, Type II
- activin receptor type II-A
|
Topics |
- Activin Receptors, Type II
(metabolism)
- Animals
- Apoptosis
(physiology)
- Autocrine Communication
(physiology)
- Bone Morphogenetic Proteins
(antagonists & inhibitors, metabolism)
- Cell Differentiation
- Disease Models, Animal
- Erythroblasts
(metabolism)
- Erythropoiesis
(drug effects)
- Fas Ligand Protein
- Gene Amplification
(physiology)
- Growth Differentiation Factors
(antagonists & inhibitors, metabolism)
- Hematinics
(pharmacology)
- Ligands
- Mice
- Oxidative Stress
(physiology)
- Reactive Oxygen Species
- Recombinant Fusion Proteins
(pharmacology)
- Signal Transduction
- beta-Thalassemia
(metabolism)
- fas Receptor
|